Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H32O2 |
Molecular Weight | 292.4562 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@@H](O)CC[C@]34C)[C@@H]1CC[C@@H]2O
InChI
InChIKey=CBMYJHIOYJEBSB-YSZCXEEOSA-N
InChI=1S/C19H32O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-17,20-21H,3-11H2,1-2H3/t12-,13-,14-,15-,16-,17-,18-,19-/m0/s1
Molecular Formula | C19H32O2 |
Molecular Weight | 292.4562 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3alpha-androstanediol and 17beta-estradiol. | 2004 |
|
The human cytochrome P4507B1: catalytic activity studies. | 2004 Dec |
|
Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate. | 2004 Dec |
|
HPLC-RIA analysis of steroid hormone profile in a virilizing stromal tumor of the ovary. | 2004 Oct 29 |
|
The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype. | 2005 Jun 15 |
|
17beta-estradiol induces apoptosis in the developing rodent prostate independently of ERalpha or ERbeta. | 2006 Jan |
|
Metabolite ligands of estrogen receptor-beta reduce primate coronary hyperreactivity. | 2006 Jan |
|
Regulation of steroid hydroxylase CYP7B1 by androgens and estrogens in prostate cancer LNCaP cells. | 2006 Jun 2 |
|
Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. | 2006 Nov |
|
Effects of 3-beta-diol, an androgen metabolite with intrinsic estrogen-like effects, in modulating the aquaporin-9 expression in the rat efferent ductules. | 2006 Oct 6 |
|
Triphenyltin alters androgen metabolism in the sea urchin Paracentrotus lividus. | 2006 Sep 12 |
|
5alpha-Androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult rats. | 2007 Dec |
|
Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma. | 2007 Sep 15 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:48:25 GMT 2025
by
admin
on
Mon Mar 31 17:48:25 GMT 2025
|
Record UNII |
6J0K4253QD
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
9640-4
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
||
|
DEA NO. |
4000
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
||
|
LOINC |
15026-8
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
||
|
LOINC |
1850-7
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
||
|
LOINC |
23815-4
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
50891
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
PRIMARY | |||
|
DTXSID8022379
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
PRIMARY | |||
|
DB03882
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
PRIMARY | |||
|
6J0K4253QD
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
PRIMARY | |||
|
209-334-3
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
PRIMARY | |||
|
3?-Androstanediol
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
PRIMARY | |||
|
18329
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
PRIMARY | |||
|
571-20-0
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
PRIMARY | |||
|
242332
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
PRIMARY | |||
|
27727
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE | |||
|
PARENT -> METABOLITE |
IN VITRO
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |